It is indicated that six months of therapy was associated with substantial salivary proteome changes and support saliva as a candidate biofluid for longitudinal molecular monitoring and non-invasive detection of treatment-associated salivary proteome variations in RRMS.
Giulia Guadalupi, C. Contini, Chiara Piras et al.· Biomolecules· 0 citations
Evidence from epidemiological, clinical, neuroimaging, biomarker, and therapeutic studies across prepubertal, peripubertal, and post-pubertal stages is synthesized to help elucidate the mechanisms driving these differences, refine early risk stratification, and support more individualized therapeutic strategies across...
L. Lorefice, R. Zivadinov· Expert Review of Neurotherap...· 0 citations
Multiple sclerosis and neuromyelitis optica spectrum disorder (NMOSD) are inflammatory demyelinating diseases of the CNS whose diagnosis is mainly based on clinical evidence, magnetic resonance imaging, and the analysis of cerebrospinal fluid (CSF). Current approaches provide only partial insight into disease-related b...
C. Contini, L. Lorefice, Greca Lai et al.· Proteomics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.